MeSH D015352 - dry eye syndromes
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Bausch Health Companies | Lifitegrast | Xiidra | 2024-11-05 | 2016-07-11 |  |  |
| Perfluorohexyloctane | Miebo | 2033-09-12 | 2023-05-18 |  |  | |
| Baxter | Dextrose, Sodium chloride, Sodium lactate | Dianeal |  | 1992-12-04 |  |  |
| Dextrose, Sodium chloride, Sodium lactate | Dianeal W/dextrose |  | 1982-01-01 |  |  | |
| Sodium chloride, Sodium bicarbonate | Phoxillum B22k |  | 2015-01-13 |  |  | |
| Dextrose, Lactic acid, Sodium chloride, Sodium bicarbonate | Prismasol |  | 2006-10-25 |  |  | |
| Eugia Pharma Specialties | Lifitegrast | Lifitegrast |  | 2023-11-07 |  |  |
| Ingenus | Lifitegrast | Lifitegrast |  | 2024-10-03 |  |  |
| Micro Laboratories | Lifitegrast | Lifitegrast |  | 2023-08-04 |  |  |
| Mylan | Polyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate | Colyte With Flavor Packs |  | 1984-10-26 |  |  |
| Nostrum Laboratories | Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate | Peg, Potassium Chloride, Bicarbonate, |  | 2017-03-08 |  |  |
| Rising Pharmaceuticals | Polyethylene glycol 3350, Tezacitabine, Sodium chloride, Sodium bicarbonate | Peg 3350 Electrolytes |  | 2010-01-28 |  |  |
| Polyethylene glycol 3350, Sodium chloride, Sodium bicarbonate | Peg, Potassium Chloride, Bicarbonate, |  | 2010-04-02 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
56%15/27
Phase 2
67%31/46
Phase 3
63%27/43
Approved: 3Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use